WGU D367 FINAL EXAM
COMPREHENSIVE STUDY GUIDE
1. Which pharmacokinetic process is primarily affected by the ‘first-pass effect’ during oral
drug administration?
A. Distribution
B. Metabolism
C. Excretion
D. Absorption
Answer: B
Conceptual Explanation: The first-pass effect refers to the rapid hepatic metabolism of a
drug as it passes through the liver from the portal vein before reaching systemic
circulation.
2. A patient is prescribed a drug with a narrow therapeutic index. What is the primary clinical
implication of this?
A. There is a small margin of safety between the effective and toxic dose.
B. The drug can be administered via multiple routes.
,C. The drug has a low potential for addiction.
D. The drug will take a long time to reach steady state.
Answer: A
Conceptual Explanation: A narrow therapeutic index means that the difference between
the dose that produces the desired effect and the dose that causes toxicity is small,
requiring careful monitoring.
3. Which of the following describes a drug that acts as a partial agonist?
A. It activates a receptor but produces a lower maximal effect than a full agonist.
B. It blocks the receptor completely without activation.
C. It increases the affinity of the receptor for the endogenous ligand.
D. It irreversibly binds to the receptor site.
Answer: A
Conceptual Explanation: Partial agonists bind to receptors but elicit a submaximal
response compared to full agonists, even at 100% receptor occupancy.
4. Which neurotransmitter is primarily associated with the parasympathetic nervous system’s
‘rest and digest’ functions?
A. Epinephrine
B. Acetylcholine
C. Norepinephrine
, D. Dopamine
Answer: B
Conceptual Explanation: Acetylcholine is the primary neurotransmitter for the
parasympathetic nervous system, acting on muscarinic and nicotinic receptors.
5. What is the mechanism of action for ACE inhibitors in treating hypertension?
A. Inhibiting the release of renin from the kidneys
B. Blocking the binding of Angiotensin II to AT1 receptors
C. Promoting the excretion of potassium in the distal tubule
D. Blocking the conversion of Angiotensin I to Angiotensin II
Answer: D
Conceptual Explanation: ACE inhibitors block the Angiotensin-Converting Enzyme,
preventing the formation of the potent vasoconstrictor Angiotensin II.
6. A patient taking Warfarin (Coumadin) needs to have their lab values monitored. Which test
is most appropriate?
A. aPTT
B. Serum Creatinine
C. PT/INR
D. Hemoglobin A1c
COMPREHENSIVE STUDY GUIDE
1. Which pharmacokinetic process is primarily affected by the ‘first-pass effect’ during oral
drug administration?
A. Distribution
B. Metabolism
C. Excretion
D. Absorption
Answer: B
Conceptual Explanation: The first-pass effect refers to the rapid hepatic metabolism of a
drug as it passes through the liver from the portal vein before reaching systemic
circulation.
2. A patient is prescribed a drug with a narrow therapeutic index. What is the primary clinical
implication of this?
A. There is a small margin of safety between the effective and toxic dose.
B. The drug can be administered via multiple routes.
,C. The drug has a low potential for addiction.
D. The drug will take a long time to reach steady state.
Answer: A
Conceptual Explanation: A narrow therapeutic index means that the difference between
the dose that produces the desired effect and the dose that causes toxicity is small,
requiring careful monitoring.
3. Which of the following describes a drug that acts as a partial agonist?
A. It activates a receptor but produces a lower maximal effect than a full agonist.
B. It blocks the receptor completely without activation.
C. It increases the affinity of the receptor for the endogenous ligand.
D. It irreversibly binds to the receptor site.
Answer: A
Conceptual Explanation: Partial agonists bind to receptors but elicit a submaximal
response compared to full agonists, even at 100% receptor occupancy.
4. Which neurotransmitter is primarily associated with the parasympathetic nervous system’s
‘rest and digest’ functions?
A. Epinephrine
B. Acetylcholine
C. Norepinephrine
, D. Dopamine
Answer: B
Conceptual Explanation: Acetylcholine is the primary neurotransmitter for the
parasympathetic nervous system, acting on muscarinic and nicotinic receptors.
5. What is the mechanism of action for ACE inhibitors in treating hypertension?
A. Inhibiting the release of renin from the kidneys
B. Blocking the binding of Angiotensin II to AT1 receptors
C. Promoting the excretion of potassium in the distal tubule
D. Blocking the conversion of Angiotensin I to Angiotensin II
Answer: D
Conceptual Explanation: ACE inhibitors block the Angiotensin-Converting Enzyme,
preventing the formation of the potent vasoconstrictor Angiotensin II.
6. A patient taking Warfarin (Coumadin) needs to have their lab values monitored. Which test
is most appropriate?
A. aPTT
B. Serum Creatinine
C. PT/INR
D. Hemoglobin A1c